Cargando...
P06.02 A multivalent protein for immune checkpoint inhibition at the tumor site
Monoclonal antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4, CTLA-4 on T cells have demonstrated efficacy in a variety of peripheral solid tumors. It is more challenging to exploit the potential of such a therapy in glioblastoma (GBM) patients becau...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464148/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.176 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|